人参皂苷抗肝纤维化作用机制研究进展

被引：18

作者：

孙媛媛 ^{[1
]}

赵玉洁 ^{[2
]}

赵金畅 ^{[2
]}

周官红 ^{[2
]}

海龙 ^{[2
]}

姜娜 ^{[2
]}

苏光悦 ^{[1
]}

赵余庆 ^{[1
,3
]}

机构：

[1] 沈阳药科大学

[2] 沈阳药科大学功能食品与葡萄酒学院

[3] 沈阳药科大学基于靶点的药物设计与研究教育部重点实验室

来源：

中草药 | 2017年 / 48卷 / 09期

关键词：

人参皂苷; 天然产物; 抗肝纤维化; 作用机制; 基质金属蛋白酶抑制剂-1; 抗氧化; 免疫调节;

D O I：

暂无

中图分类号：

R285 [中药药理学];

学科分类号：

100806 [中药药理学];

摘要：

人参皂苷是一类重要的天然产物,在自然界中分布广泛,是多种药用植物中的主要活性成分,具有多种生理活性。研究发现,人参皂苷在肿瘤疾病治疗中取得很大进展,同时在抗肝纤维化方面也有显著的作用。因此人参皂苷对肝纤维化的治疗具有重要的应用价值。对人参皂苷的抗肝纤维化作用机制进行综述,以便为今后进一步的研究提供理论依据。

引用

页码：1912 / 1915

页数：4

共 29 条

[1]

山茱萸新苷和人参皂苷肝保护及抗肝纤维化作用的研究 [D].

宋顺宗 .

延边大学,

2011

[2]

Hepatic Macrophages But Not Dendritic Cells Contribute to Liver Fibrosis by Promoting the Survival of Activated Hepatic Stellate Cells in Mice [J].

Pradere, Jean-Philippe ;

Kluwe, Johannes ;

De Minicis, Samuele ;

Jiao, Jing-Jing ;

Gwak, Geum-Youn ;

Dapito, Dianne H. ;

Jang, Myoung-Kuk ;

Guenther, Nina D. ;

Mederacke, Ingmar ;

Friedman, Richard ;

Dragomir, Ana-Cristina ;

Aloman, Costica ;

Schwabe, Robert F. .

HEPATOLOGY, 2013, 58 (04) :1461-1473

[3]

Dendritic cells limit fibroinflammatory injury in nonalcoholic steatohepatitis in mice [J].

Henning, Justin R. ;

Graffeo, Christopher S. ;

Rehman, Adeel ;

Fallon, Nina C. ;

Zambirinis, Constantinos P. ;

Ochi, Atsuo ;

Barilla, Rocky ;

Jamal, Mohsin ;

Deutsch, Michael ;

Greco, Stephanie ;

Ego-Osuala, Melvin ;

Bin-Saeed, Usama ;

Rao, Raghavendra S. ;

Badar, Sana ;

Quesada, Juan P. ;

Acehan, Devrim ;

Miller, George .

HEPATOLOGY, 2013, 58 (02) :589-602

[4]

Hedgehog Controls Hepatic Stellate Cell Fate by Regulating Metabolism [J].

Chen, Yuping ;

Choi, Steve S. ;

Michelotti, Gregory A. ;

Chan, Isaac S. ;

Swiderska-Syn, Marzena ;

Karaca, Gamze F. ;

Xie, Guanhua ;

Moylan, Cynthia A. ;

Garibaldi, Francesca ;

Premont, Richard ;

Suliman, Hagir B. ;

Piantadosi, Claude A. ;

Diehl, Anna Mae .

GASTROENTEROLOGY, 2012, 143 (05) :1319-+

[5]

Extracellular matrix degradation in liver fibrosis: Biochemistry and regulation.[J].John P. Iredale;Alexandra Thompson;Neil C. Henderson.BBA - Molecular Basis of Disease.2012,

[6]

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study.[J].Patrick Marcellin;Edward Gane;Maria Buti;Nezam Afdhal;William Sievert;Ira M Jacobson;Mary Kay Washington;George Germanidis;John F Flaherty;Raul Aguilar Schall;Jeffrey D Bornstein;Kathryn M Kitrinos;G Mani Subramanian;John G McHutchison;E Jenny Heathcote.The Lancet.2012,

[7]

Retinoic acids and hepatic stellate cells in liver disease.[J].Young‐SunLee;Won‐IlJeong.Journal of Gastroenterology and Hepatology.2012,

[8]

25-OCH 3 -PPD induces the apoptosis of activated t-HSC/Cl-6 cells via c-FLIP-mediated NF-κB activation.[J].Yan-ling Wu;Ying Wan;Xue-Jun Jin;Bing-Qing OuYang;Ting Bai;Yu-Qing Zhao;Ji-Xing Nan.Chemico-Biological Interactions.2011, 2

[9]

Long-Term Entecavir Therapy Results in the Reversal of Fibrosis/Cirrhosis and Continued Histological Improvement in Patients with Chronic Hepatitis B [J].

Chang, Ting-Tsung ;

Liaw, Yun-Fan ;

Wu, Shun-Sheng ;

Schiff, Eugene ;

Han, Kwang-Hyub ;

Lai, Ching-Lung ;

Safadi, Rifaat ;

Lee, Samuel S. ;

Halota, Waldemar ;

Goodman, Zachary ;

Chi, Yun-Chan ;

Zhang, Hui ;

Hindes, Robert ;

Iloeje, Uchenna ;

Beebe, Suzanne ;

Kreter, Bruce .

HEPATOLOGY, 2010, 52 (03) :886-893

[10]

Ginsenoside-Rg1 from Panax notoginseng prevents hepatic fibrosis induced by thioacetamide in rats.[J].JiaWei Geng;Wei Peng;YouGuang Huang;Hong Fan;ShuDe Li.European Journal of Pharmacology.2010, 1

← 1 2 3 →